Covered recipient · General Payments record
TAYLORE DAWN KUSEL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$1,454.11
- Reported across 89 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $550.91 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $335.01 | 21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $78.22 | 1 |
| ABBVIE INC. | $70.15 | 4 |
| Lilly USA, LLC | $18.89 | 1 |
| GlaxoSmithKline, LLC. | $18.46 | 1 |
| DEXCOM, INC. | $16.14 | 1 |
| Currax Pharmaceuticals LLC | $14.04 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.70 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107494106 | CMS |
| ABBVIE INC. | $21.58 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107494108 | CMS |
| ABBVIE INC. | $18.19 | 02/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107494110 | CMS |
| ABBVIE INC. | $13.68 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107494112 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $78.22 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118073964 | CMS |
| Currax Pharmaceuticals LLC | $14.04 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089525577 | CMS |
| Dexcom, Inc. | $16.14 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153389330 | CMS |
| GlaxoSmithKline, LLC. | $18.46 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116233616 | CMS |
| Lilly USA, LLC | $18.89 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135963856 | CMS |
| Novo Nordisk Inc | $14.24 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100643467 | CMS |
| Novo Nordisk Inc | $16.51 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100363885 | CMS |
| Novo Nordisk Inc | $14.61 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100442475 | CMS |
| Novo Nordisk Inc | $16.32 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100322536 | CMS |
| Novo Nordisk Inc | $15.90 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100633825 | CMS |
| Novo Nordisk Inc | $18.19 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100340064 | CMS |
| Novo Nordisk Inc | $15.90 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100309047 | CMS |
| Novo Nordisk Inc | $17.74 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100346184 | CMS |
| Novo Nordisk Inc | $15.47 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100610248 | CMS |
| Novo Nordisk Inc | $16.92 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100348348 | CMS |
| Novo Nordisk Inc | $16.86 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100386399 | CMS |
| Novo Nordisk Inc | $16.92 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100575614 | CMS |
| Novo Nordisk Inc | $15.52 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100531835 | CMS |
| Novo Nordisk Inc | $16.49 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100347098 | CMS |
| Novo Nordisk Inc | $17.73 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100298659 | CMS |
| Novo Nordisk Inc | $20.13 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100498303 | CMS |
| Novo Nordisk Inc | $16.64 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100550452 | CMS |
| Novo Nordisk Inc | $17.56 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100571254 | CMS |
| Novo Nordisk Inc | $16.64 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100279546 | CMS |
| Novo Nordisk Inc | $17.48 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100272196 | CMS |
| Novo Nordisk Inc | $1.24 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100492707 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.